These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295 [TBL] [Abstract][Full Text] [Related]
45. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927 [TBL] [Abstract][Full Text] [Related]
46. 5-aminolevulinic acid-induced (ALA) fluorescence for the laparoscopic diagnosis of peritoneal metastasis. AST An experimental study. Canis M; Botchorishvili R; Berreni N; Manhes H; Wattiez A; Mage G; Pouly JL; Bruhat MA Surg Endosc; 2001 Oct; 15(10):1184-6. PubMed ID: 11727098 [TBL] [Abstract][Full Text] [Related]
47. Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination. Duggan BD; Wan M; Yu MC; Roman LD; Muderspach LI; Delgadillo E; Li WZ; Martin SE; Dubeau L J Natl Cancer Inst; 1998 Feb; 90(3):238-42. PubMed ID: 9462682 [TBL] [Abstract][Full Text] [Related]
48. Significance of peritoneal washings in gynecologic oncology. The experience with 901 intraoperative washings at an academic medical center. Mathew S; Erozan YS Arch Pathol Lab Med; 1997 Jun; 121(6):604-6. PubMed ID: 9199626 [TBL] [Abstract][Full Text] [Related]
49. [The value of peritoneal cytology in the staging of ovarian cancer]. Emerich J; Konefka T; Dudziak M; Sobol A Ginekol Pol; 1997 Feb; 68(2):74-7. PubMed ID: 9499000 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection. Vadva Z; Laufer MR; Weldon CB; Frazier AL; Vargas SO Pediatr Dev Pathol; 2016; 19(5):401-408. PubMed ID: 26579785 [TBL] [Abstract][Full Text] [Related]
51. Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Nouriani M; Bahador A; Berek JS; Cheng JP; Chi DS; Cliby WA; Del Priore G; Dodson MK; Duggan BD; Gershenson DM; Lentz SE; Penson RT; Robinson WR; Rodriguez M; Roman LD; Yu MC; Zempolich K; Dubeau L Clin Cancer Res; 2004 Apr; 10(8):2681-6. PubMed ID: 15102671 [TBL] [Abstract][Full Text] [Related]
52. The utility of peritoneal biopsy and omentectomy in the upstaging of apparent early ovarian cancer. Shroff R; Brooks RA; Zighelboim I; Powell MA; Thaker PH; Mutch DG; Massad LS Int J Gynecol Cancer; 2011 Oct; 21(7):1208-12. PubMed ID: 21633295 [TBL] [Abstract][Full Text] [Related]
53. The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors. Mottolese M; Salzano M; Vincenzoni C; Benevolo M; Bigotti A; Iacovelli A; Lombardi A; Atlante G; Natali PG Cancer; 1991 Oct; 68(8):1803-7. PubMed ID: 1833045 [TBL] [Abstract][Full Text] [Related]
54. Is cell block technique useful to predict histological type in patients with ovarian mass and/or body cavity fluids? Maseki Z; Kajiyama H; Nishikawa E; Satake T; Misawa T; Kikkawa F Nagoya J Med Sci; 2020 May; 82(2):225-235. PubMed ID: 32581403 [TBL] [Abstract][Full Text] [Related]
55. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids. Mulvany N Acta Cytol; 1996; 40(6):1231-9. PubMed ID: 8960034 [TBL] [Abstract][Full Text] [Related]
56. Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy. Galic Jerman K; Kobal B; Jakimovska M; Verdenik I; Cerne K World J Surg Oncol; 2014 Sep; 12():278. PubMed ID: 25185697 [TBL] [Abstract][Full Text] [Related]
57. Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration. Powless CA; Bakkum-Gamez JN; Aletti GD; Cliby WA Gynecol Oncol; 2009 Oct; 115(1):86-89. PubMed ID: 19631972 [TBL] [Abstract][Full Text] [Related]
58. The diagnostic accuracy and prognostic implication of pelvic and peritoneal fluid cytology specimens in ovarian clear cell carcinoma. Marshall M; Elishaev E; Khader S J Am Soc Cytopathol; 2024; 13(1):53-58. PubMed ID: 37865568 [TBL] [Abstract][Full Text] [Related]
59. Practical Approach to the Evaluation of Malignant Peritoneal Fluids in the Setting of Gynecologic Neoplasms. Mendoza RP; Lastra RR Acta Cytol; 2023; 67(2):143-175. PubMed ID: 36572015 [TBL] [Abstract][Full Text] [Related]
60. Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted? Algera MD; van Driel WJ; van de Vijver KK; Kruitwagen RFPM; Lok CAR Curr Opin Oncol; 2022 Sep; 34(5):497-503. PubMed ID: 35838205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]